MolNFT v1 · #40876 · protein
N-terminal SH3 domain of cms (CD2AP human homolog) bound to cbl-B peptide
2J6F · CD2-associated protein: “N-terminal SH3 domain of cms (CD2AP human homolog) bound to cbl-B peptide”. X-ray diffraction. MolNFT v1 #40876 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2J6F
- Type
- protein
- Length
- 65 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- CD2-associated protein; E3 ubiquitin-protein ligase cbl-B
- EC
- 6.3.2.-
- UniProt
- Q9Y5K6, Q13191
Structure
x-ray diffraction · 2 distinct chains · 5% helix, 43% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | CD2-associated protein | protein | 57 | 5% helix, 49% strand | Q9Y5K6 |
| C | E3 ubiquitin-protein ligase cbl-B (EC 6.3.2.-) | protein | 8 | 0% helix, 0% strand | Q13191 |
Interfaces
1 interface between chains.
- A–C · 502 Ų buried · 8 hydrogen bonds · protein-protein
Compared structures
- 2J6F · N-terminal SH3 domain of cms (CD2AP human homolog) bound to cbl-B peptide · the same entry in another collection · chain A against A, TM-score 1.00
- Q9Y5K6 · AlphaFold monomer V2.0 prediction for CD2-associated protein (Q9Y5K6) · a predicted model of the same protein · chain A against A, TM-score 0.98
- Q13191 · AlphaFold monomer V2.0 prediction for E3 ubiquitin-protein ligase cbl-B (Q13191) · a predicted model of the same protein · chain C against A, TM-score 0.55
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9Y5K6
- Every structure of UniProt Q13191
- Elsewhere: RCSB PDB 2J6F · PDBe 2J6F · UniProt Q9Y5K6 · UniProt Q13191
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.